First Manhattan
DSCI

First Manhattan’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

First Manhattan’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-500,000
Closed -$5.41M – 1530
2013
Q4 		$5.41M Hold
500,000
– – 0.04% 232
2013
Q3 		$6.19M Hold
500,000
– – 0.04% 206
2013
Q2 		$7.26M Buy
+500,000
New +$6.43M 0.05% 189

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

First Manhattan's DSCI Position: Q1 2014 in Review

First Manhattan sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2014, closing a stake of 500,000 shares — an estimated $5.41M sold.

First Manhattan first reported a position in DSCI in Q2 2013 and held it in 3 quarters. The position peaked at $7.26M in Q2 2013. 71 funds tracked by Wall St. Rank hold DSCI as of Q1 2014.

  • First Manhattan reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2014 after selling out during the quarter.
  • First Manhattan sold 500,000 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2014, an estimated $5.41M.
  • First Manhattan first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 3 quarters.
  • First Manhattan's Derma Sciences, Inc. Common Stock (DE) position peaked at $7.26M in Q2 2013.
  • 71 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2014.

Based on First Manhattan's 13F filing for Q1 2014, filed 16 May 2014.